dbo:abstract
|
- CP-809101 is a drug which acts as a potent and selective 5-HT2C receptor agonist. It had promising results in animal models of obesity and psychosis, but associated with genotoxicity which means that future use will be restricted to scientific research applications only. (en)
- CP-809101 es un fármaco que actúa como un potente y selectivo agonista del receptor 5-HT2C. Tuvo resultados prometedores en modelos animales de obesidad y psicosis, pero se asoció con genotoxicidad, lo que significa que su uso futuro se limitará únicamente a aplicaciones de investigación científica. (es)
|
dbo:casNumber
| |
dbo:fdaUniiCode
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 3548 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chemspiderid
| |
dbp:cl
| |
dbp:h
| |
dbp:iupacName
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:smiles
|
- C2CNCCN2ccncc3OCccccc1Cl (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- PCWGGOVOEWHPMG-UHFFFAOYSA-N (en)
|
dbp:unii
| |
dbp:verifiedfields
| |
dbp:verifiedrevid
| |
dbp:watchedfields
| |
dbp:width
| |
dbp:wikiPageUsesTemplate
| |
dct:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- CP-809101 is a drug which acts as a potent and selective 5-HT2C receptor agonist. It had promising results in animal models of obesity and psychosis, but associated with genotoxicity which means that future use will be restricted to scientific research applications only. (en)
- CP-809101 es un fármaco que actúa como un potente y selectivo agonista del receptor 5-HT2C. Tuvo resultados prometedores en modelos animales de obesidad y psicosis, pero se asoció con genotoxicidad, lo que significa que su uso futuro se limitará únicamente a aplicaciones de investigación científica. (es)
|
rdfs:label
|
- CP-809101 (es)
- CP-809101 (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |